In triple-negative breast cancer, MIR210HG potentiated the metabolic transcription factor HIF-1α translation via directly binding to the 5’-UTR of HIF-1α mRNA, leading to increased HIF-1a protein level (34). Here, HIF1A is linked to triple-negative breast carcinoma.